BioCardia
BCDA
BCDA
23 hedge funds and large institutions have $3.17M invested in BioCardia in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
12% less funds holding
Funds holding: 26 → 23 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Holders
23
Holding in Top 10
–
Calls
$571K
Puts
$179K
Top Buyers
| 1 | +$276K | |
| 2 | +$55.1K | |
| 3 | +$40.9K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$6.71K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$5.78K |
Top Sellers
| 1 | -$958K | |
| 2 | -$26K | |
| 3 | -$18K | |
| 4 |
Millennium Management
New York
|
-$13.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$5.37K |